Yoshiteru proved that inhibition of macrophagic PGE2 synthesis is an effective treatment for the induction of anti-glioma immune response (85)
There is only one clinical trial for lixisenatide in PD, assessing its efficacy in slowing motor disability progression in early-stage patients over 12 months, followed by a 2-month washout period
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Yan YQ, Liu M, Xu ZJ, Xu ZJ, Huang YX, Li XM, et al
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial
LlavaneraMMateo-OteroYBonetSBarrancoIFernndez-FuertesBYesteM